The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when fully launched, would outpace the rate for an older model.
Source: https://www.medtechdive.com/news/Stereotaxis-GenesisX-surgical-robot-FDA-clearance/805267/
Leave a Reply